|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
Drug Discovery Technology – Europe | ||||||||||||||||
November 06, 2001 | ||||||||||||||||
IBC Life Sciences, Messe Stuttgart International, Germany 15 – 18 April 2002 Sessions Include Science streams • Medicinal and analytical chemistry • Lead generation and optimisation • ADMET • Target validation • Proteomics and protein structure Including • Emerging technologies • Informatics • Real data Business • Outsourcing • Biotech start-ups • Patenting • Alliances and partnering • Strategic management of drug discovery |
||||||||||||||||
Organized by: | IBC Life Sciences | |||||||||||||||
Invited Speakers: | Keynotes Include - Dr Steven Paul, Group Vice-President, Lilly Research Laboratories, Eli Lilly, USA - Dr Martin MacKay, Senior Vice-President of Worldwide Discovery, Pfizer, USA - Dr George Rathmann, Chairman, Hyseq, USA - Dr John P. McKearn, Senior Vice President, Pharmacia Discovery Research, USA |
|||||||||||||||
Deadline for Abstracts: | 1 Jan 02 | |||||||||||||||
Registration: | http://www.drugdisc.com/europe/?src=eu235 | |||||||||||||||
E-mail: | Cust.serv@informa.com | |||||||||||||||
Posted by: | Chris Marshall | |||||||||||||||
Host: | dc-01.informa.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |